EGFR and neoplasm: However, no clear association has been found between the expression level of the EGFR protein in the tumours, determined by the FDA approved EGFR PharmDxTM kit, or other standard anti-EGFR antibodies, and the response to the EGFR inhibitors [3, 9–12].